Exyte Acquires TTP Group to Expand Biopharma and Life Sciences Engineering Presence

November 5, 2024

Exyte plans to acquire TTP Group (brands Pharmaplan and Triplan), a European consulting and engineering firm serving the pharmaceutical and chemical process industries. The acquisition combines TTP’s engineering expertise with Exyte’s biopharma and life sciences activities to strengthen capabilities and market presence in Europe.

Buyers
Exyte
Targets
TTP Group
Sellers
Robus Capital, minority shareholders of TTP
Location
Baden-Württemberg, Germany
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.